Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: NO release

September 16, 2024 Drug delivery / Pharma applications

Multifunctional Molecular Hybrids Photoreleasing Nitric Oxide: Advantages, Pitfalls, and Opportunities

The multifaceted role nitric oxide (NO) plays in human physiology and pathophysiology has opened new scenarios in biomedicine by exploiting

Continue reading

August 5, 2024 Drug delivery / Pharma applications

Pulmonary Vasodilating Effects of a New Drug Formulation Containing a NO Donor Metabolite (SIN-1A) stabilized by CD

Sin1A is an unstable NO releasing metabolite of Molsidomine. Molsidomine is a prodrug that undergoes first-pass metabolism in the liver,

Continue reading

March 31, 2023 Drug delivery / Pharma applications / Supramolecular systems

Nitric Oxide-Releasing Topological Supramolecular Nanocarriers with sliding CD units against MRSA

Polymeric systems that provide cationic charges or biocide-release therapeutics are used to treat the bacteria-infected wound. However, most antibacterial polymers

Continue reading

October 27, 2022 Drug delivery / Pharma applications

Inclusion Complexation of S-Nitrosoglutathione for Sustained NO Release and Reduced Device Infection

S-nitrosoglutathione (GSNO) is a non-toxic nitric oxide (NO)-donating compound that occurs naturally in the human body. The use of GSNO

Continue reading

January 6, 2022 CD as API / Pharma applications

Beta-Cyclodextrin/L-Arginine/Au Nanomotors for Atherosclerosis

Most of the current non-pharmacological treatment strategies for atherosclerosis (AS) suffer from poor penetration into the plaque and only aim

Continue reading

April 12, 2021 CD derivatives / Drug delivery / Pharma applications

Visible Light-Activatable Cyclodextrin-Conjugates for the Efficient Delivery of Nitric Oxide with Fluorescent Reporter and their Inclusion Complexes with Betaxolol

Novel multifunctional drug delivery systems were developed by the Sortino’s group [1]. βCD-NBFNO1 and βCD-NBFNO2, covalently integrating an N-nitroso amino-nitro-benzofurazan

Continue reading

September 15, 2020 CD as API / Pharma applications

Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds: a patent evaluation of US2019343869(A1)

Introduction: Antimicrobial resistance is one of the major scourges for healthcare worldwide, therefore novel investigational approaches are needed to potentiate and

Continue reading

June 7, 2019 CD as API / CD derivatives

NO-delivering fluorescent beta-cyclodextrin polymer

A novel water-soluble β-cyclodextrin branched polymer covalently integrating a fluorescein moiety and a nitric oxide (NO) photodonor within its macromolecular

Continue reading

January 2, 2019 CD as API / CD derivatives / Cosmetics and toilettry / Drug delivery / Gene delivery / Non-pharma applications / Pharma applications

Cyclodextrin News Year in Review 2018

The CDNews blog was created in July and after a short period of trial it started in September. During this

Continue reading

November 29, 2018 CD as API / CD derivatives / Drug delivery / Pharma applications

NO-releasing cyclodextrins

Nitric oxide (NO) is a signaling molecule produced by almost all types of organisms ranging from bacteria to plants and

Continue reading

Recent Posts

  • Fast-Dissolving Cyclodextrin Nanofibers for Pain Relief
  • Concluding 22nd International Cyclodextrin Symposium (ICS-22)
  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • Book chapter: Functionalized cyclodextrins in drug delivery
  • β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (361)
  • CD derivatives (443)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (833)
  • E-ducation (64)
  • Environmental (144)
  • Events (243)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (428)
  • Other industrial use (114)
  • Pharma applications (1,242)
  • Supramolecular systems (45)
  • Uncategorized (176)

Top Posts

  • Concluding 22nd International Cyclodextrin Symposium (ICS-22)
  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • Fast-Dissolving Cyclodextrin Nanofibers for Pain Relief
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Rafael Holdings Announced Submission of New Drug Application to FDA for Trappsol®Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
  • Cyclodextrins in 3D and 4D printing
  • Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity
  • A new multi-compendia modified beta-cyclodextrin, Kleptose® HPB-LB parenteral grade
  • Future automobiles made from supramolecular polymers are reality?

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,471 other subscribers
Loading Comments...